Advanced Search

Oncology & Hematology Coding Alert

Reader Questions:

NOC Code Holds the Ixabepilone Key

Published on Fri Jan 19, 2007

Question: What HCPCS code should I use for ixabepilone? Tennessee Subscriber Answer: You should report J9999 (NOC, antineoplastic drug). The FDA recently approved ixabepilone for breast cancer treatment, and HCPCS doesn't offer a specific code for this drug. Important: Your claim for an unlisted code should include a description of the drug and the exact dose the patient received. Check your payer: Tennessee Part B carrier Cigna, for example, includes ixabepilone coverage for metastatic or locally advanced breast cancer codes 174.0-175.9 in its "4th Quarter Update Part B Not Otherwise Classified Drug Fee Schedule," at www.cignagovernmentservices.com/partb/coverage/fees/noc/2007_Q4_NOC.html. You should include an invoice for payment.
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in your eNewsletter
  • 6 annual AAPC-approved CEUs*
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more
*CEUs available with select eNewsletters.

Other Articles in this issue of

Oncology & Hematology Coding Alert

View All